CLINICAL TRIALS PROFILE FOR ZULRESSO
✉ Email this page to a colleague
All Clinical Trials for ZULRESSO
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04273191 ↗ | A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone) | Withdrawn | Sage Therapeutics | Phase 4 | 2020-02-01 | In this Phase 4 study, women who have been prescribed commercial ZULRESSO™ (brexanolone) by a physician as standard of care for postpartum depression (PPD) and who are planning to receive the infusion per United States Prescribing Information (USPI) at a Risk Evaluation and Mitigation Strategy (REMS)-certified healthcare center are being asked to participate to collect data on multimodal neuroimaging parameters in order to evaluate the relationship between changes in depressive symptoms and changes in neuroimaging parameters. |
| NCT04537806 ↗ | A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19 | Terminated | Sage Therapeutics | Phase 3 | 2020-12-18 | The purpose of this study is to evaluate the efficacy and safety of brexanolone in participants on ventilator support for acute respiratory distress syndrome (ARDS) due to COVID-19. |
| NCT05059600 ↗ | A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting | Not yet recruiting | Sage Therapeutics | Phase 4 | 2021-11-01 | The primary purpose of this study is to evaluate whether the safe-use conditions for administration of brexanolone (ZULRESSO®) can be implemented in a home setting. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ZULRESSO
Condition Name
Clinical Trial Locations for ZULRESSO
Trials by Country
Clinical Trial Progress for ZULRESSO
Clinical Trial Phase
Clinical Trial Sponsors for ZULRESSO
Sponsor Name
